Genomics offers a novel way to detect disease long before symptoms may present themselves. Our suite of offerings help to identify a patient’s susceptibility to cancer and other diseases so caregivers can recommend personalized, preventive, care plans.

Our suite of precision therapy programs uses genomic testing to personalize treatment plans. For example, PGx testing identifies gene variations to improve medication prescribing, minimizing adverse drug reactions. Likewise, if a patient develops cancer, Comprehensive Genomic Profiling (CPG) tests can diagnose genetic anomalies in the tumor to guide targeted therapies.

Providence uses research and data to develop new precision medicine breakthroughs and integrates these innovations across our healthcare system.  As an accelerant for system change, the Discover Program is helping us build a healthcare system of the future – one where whole-person precision medicine is fully integrated into the standard of care for all patients.